Mingjing Peng

1.2k total citations · 3 hit papers
35 papers, 659 citations indexed

About

Mingjing Peng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Mingjing Peng has authored 35 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Immunology. Recurrent topics in Mingjing Peng's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (6 papers). Mingjing Peng is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (6 papers). Mingjing Peng collaborates with scholars based in China, United States and Netherlands. Mingjing Peng's co-authors include Qianjin Liao, Xianjie Jiang, Linda Oyang, Nayiyuan Wu, Yujuan Zhou, Jinguan Lin, Yanyan Tang, Longzheng Xia, Shiming Tan and Xuemeng Xu and has published in prestigious journals such as Scientific Reports, International Journal of Cancer and Applied Surface Science.

In The Last Decade

Mingjing Peng

34 papers receiving 655 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential

2023 121 citations Xuemeng Xu, Peng Qiu et al. Experimental & Molecular Medicine profile →
Endoplasmic reticulum stress—a key guardian in cancer

2024 62 citations Wenlong Zhang, Yidan Shi et al. Cell Death Discovery profile →
The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications

2025 36 citations Xianjie Jiang, Peng Qiu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingjing Peng China	14	394	195	120	109	104	35	659
Shan Pan China	14	421 1.1×	253 1.3×	95 0.8×	77 0.7×	100 1.0×	30	671
Ningjing Lei China	16	453 1.1×	272 1.4×	111 0.9×	78 0.7×	111 1.1×	38	691
Jiazhang Wei China	14	324 0.8×	194 1.0×	94 0.8×	75 0.7×	126 1.2×	46	606
Hongyu Zheng China	12	356 0.9×	204 1.0×	144 1.2×	57 0.5×	121 1.2×	33	677
Maryam Moradi Binabaj Iran	14	314 0.8×	177 0.9×	67 0.6×	102 0.9×	113 1.1×	30	655
Z. Q. Teo Singapore	16	321 0.8×	330 1.7×	102 0.8×	67 0.6×	156 1.5×	27	974
Reid Loveless United States	11	332 0.8×	137 0.7×	127 1.1×	94 0.9×	85 0.8×	14	507
Chiung‐Fang Chang Taiwan	15	410 1.0×	152 0.8×	172 1.4×	80 0.7×	227 2.2×	32	838
Jin Jiang China	17	403 1.0×	222 1.1×	154 1.3×	130 1.2×	124 1.2×	31	691

Countries citing papers authored by Mingjing Peng

Since Specialization

Citations

This map shows the geographic impact of Mingjing Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjing Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjing Peng more than expected).

Fields of papers citing papers by Mingjing Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjing Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjing Peng. The network helps show where Mingjing Peng may publish in the future.

Co-authorship network of co-authors of Mingjing Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingjing Peng. A scholar is included among the top collaborators of Mingjing Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingjing Peng. Mingjing Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Haoneng, Peng Qiu, Linda Oyang, et al.. (2025). Fusion genes in cancers: Biogenesis, functions, and therapeutic implications. Genes & Diseases. 12(5). 101536–101536.

Qiu, Peng, Lujuan Wang, Ying Long, et al.. (2025). SRSF9 mediates oncogenic RNA splicing of SLC37A4 via liquid–liquid phase separation to promote oral cancer progression. Journal of Advanced Research. 79. 505–520. 3 indexed citations

Qiu, Peng, Xuemeng Xu, Wenlong Zhang, et al.. (2025). Crosstalk between RNA-binding proteins and non-coding RNAs in tumors: molecular mechanisms, and clinical significance. International Journal of Biological Sciences. 21(7). 2991–3010. 3 indexed citations

Tan, Shiming, Shizhen Li, Longzheng Xia, et al.. (2025). Long non‑coding RNA ABHD11‑AS1 inhibits colorectal cancer progression through interacting with EGFR to suppress the EGFR/ERK signaling pathway. International Journal of Oncology. 66(3). 1 indexed citations

Han, Yaqian, Shizhen Li, Linda Oyang, et al.. (2025). Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential. Cellular Oncology. 48(5). 1219–1244. 1 indexed citations

Jiang, Xianjie, Peng Qiu, Linda Oyang, et al.. (2025). The cGAS‒STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications. Journal of Hematology & Oncology. 18(1). 40–40. 36 indexed citations breakdown →

Wang, Jiewen, Mingjing Peng, Linda Oyang, et al.. (2025). Mechanism and application of lactylation in cancers. Cell & Bioscience. 15(1). 76–76. 4 indexed citations

Jiang, Xianjie, Qiu Peng, Mingjing Peng, et al.. (2024). Cellular metabolism: A key player in cancer ferroptosis. Cancer Communications. 44(2). 185–204. 36 indexed citations

Jiang, Xianjie, Mingjing Peng, Qiang Liu, et al.. (2024). Circular RNA hsa_circ_0000467 promotes colorectal cancer progression by promoting eIF4A3-mediated c-Myc translation. Molecular Cancer. 23(1). 151–151. 13 indexed citations

10.

Zhang, Wenlong, Yidan Shi, Linda Oyang, et al.. (2024). Endoplasmic reticulum stress—a key guardian in cancer. Cell Death Discovery. 10(1). 343–343. 62 indexed citations breakdown →

11.

Xia, Longzheng, Jinguan Lin, Mingjing Peng, et al.. (2024). Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. International Journal of Biological Sciences. 20(4). 1125–1141. 8 indexed citations

12.

Xu, Xuemeng, Qiu Peng, Xianjie Jiang, et al.. (2024). Altered glycosylation in cancer: molecular functions and therapeutic potential. Cancer Communications. 44(11). 1316–1336. 39 indexed citations

13.

Hu, Qi, Shuai Chen, Rilin Deng, et al.. (2024). Exosomal PDL1 Suppresses the Anticancer Activity of CD8⁺ T Cells in Hepatocellular Carcinoma. Analytical Cellular Pathology. 2024(1). 1608582–1608582. 4 indexed citations

14.

Li, Shizhen, Mingjing Peng, Shiming Tan, et al.. (2024). The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. Cancer Cell International. 24(1). 37–37. 15 indexed citations

15.

Zeng, Hui, Jinfeng Wang, Hongyu Deng, et al.. (2023). Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma. Oncology Reports. 49(5). 6 indexed citations

16.

Xu, Xuemeng, Peng Qiu, Xianjie Jiang, et al.. (2023). Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. Experimental & Molecular Medicine. 55(7). 1357–1370. 121 indexed citations breakdown →

17.

Wang, Jiewen, Nayiyuan Wu, Mingjing Peng, et al.. (2023). Ferritinophagy: research advance and clinical significance in cancers. Cell Death Discovery. 9(1). 463–463. 53 indexed citations

18.

Qiu, Peng, Lujuan Wang, Liang Zuo, et al.. (2023). HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor. Cancer Gene Therapy. 31(1). 9–17. 31 indexed citations

19.

Peng, Mingjing, Songqing Fan, Junjun Li, et al.. (2022). Programmed death-ligand 1 signaling and expression are reversible by lycopene via PI3K/AKT and Raf/MEK/ERK pathways in tongue squamous cell carcinoma. Genes & Nutrition. 17(1). 3–3. 15 indexed citations

20.

Zhang, Hailin, Bocheng Zhang, Mingjing Peng, et al.. (2021). MicroRNA-2355-5p Promotes the Proliferation of Head and Neck Squamous Cell Carcinoma via Suppressing NISCH Expression. Journal of Oncology. 2021. 1–11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact